Sophia Genetics Sa (SOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,495 | -54,442 | -40,916 | -19,593 | -87,585 |
| Depreciation Amortization | 8,336 | 6,355 | 4,154 | 1,890 | 5,571 |
| Accounts receivable | -6,500 | -2,880 | -834 | -3,169 | 1,332 |
| Accounts payable and accrued liabilities | 6,871 | 2,284 | 3,749 | 2,062 | -1,428 |
| Other Working Capital | 872 | -3,793 | 910 | -1,090 | -1,273 |
| Other Operating Activity | 20,341 | 15,193 | 7,824 | 5,111 | 13,290 |
| Operating Cash Flow | $-48,575 | $-37,283 | $-25,113 | $-14,789 | $-70,093 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,546 | N/A | 17,546 | 16,213 | 78,533 |
| PPE Investments | -1,494 | -1,369 | -1,246 | -508 | -4,097 |
| Purchase Of Investment | N/A | 17,546 | N/A | N/A | -26,179 |
| Purchase Sale Intangibles | -263 | -1,033 | -788 | -284 | -464 |
| Other Investing Activity | -7,732 | -5,608 | -3,630 | -1,219 | -6,284 |
| Investing Cash Flow | $8,320 | $10,569 | $12,670 | $14,486 | $41,973 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 226 | 207 | 207 | 151 | 748 |
| Other Financing Activity | -3,043 | -2,518 | -1,761 | -1,086 | -2,316 |
| Financing Cash Flow | $-2,817 | $-2,311 | $-1,554 | $-935 | $-1,568 |
| Exchange Rate Effect | 5,018 | 487 | 1,244 | 695 | -1,969 |
| Beginning Cash Position | 161,305 | 161,305 | 161,305 | 161,305 | 192,962 |
| End Cash Position | 123,251 | 132,767 | 148,552 | 160,762 | 161,305 |
| Net Cash Flow | $-38,054 | $-28,538 | $-12,753 | $-543 | $-31,657 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,575 | -37,283 | -25,113 | -14,789 | -70,093 |
| Capital Expenditure | -1,494 | -1,369 | -1,246 | -508 | -4,097 |
| Free Cash Flow | -50,069 | -38,652 | -26,359 | -15,297 | -74,190 |